Brind.
  1. Morgan Stanley sees Chewy positioned in the veterinary market, noting the company benefits from Trump-era tariffs and onshoring trends.

Morgan Stanley named Chewy its top stock pick, citing that the company's existing health business generates over $3 billion in sales.

1 report, 0 independent Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Morgan Stanley named Chewy its top stock pick, citing that the company's existing health business generates over $3 billion in sales.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet